Most people marvel at the level of innovation demonstrated by the biopharmaceutical industry in bringing new products to the market – especially in the past 20 years. However, there is a crisis looming in the industry that should be a concern to all of us who take for granted the constant pace at which new treatments, and increasingly cures, have emerged from the laboratories of current sector incumbents. In the book, we examine the evolution of the biopharmaceutical industry to understand how it became what we term a "unicorn industry" with a unique, US-centered business model that has led to multiple blockbuster products (aka, unicorns) year after year. We explore how past success has created perceived barriers to innovation diversification beyond the chemical or biological-based biopharmaceutical product, and highlight the warning signs of the industry’s decline. We define a potential pathway for transforming the industry’s business model by broadening the definition, sources, and enablers of innovation beyond the traditional biopharmaceutical product. We introduce and advocate for the 80-80 Rule - "Being 80% confident that you will only be 80% right the first time should feel normal." The 80-80 Rule is a theme that emphasizes speed and willingness to embrace uncertainty and overcome internal barriers to change. It sets the standard for redefining innovation as a platform to reignite growth of the biopharmaceutical industry.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Ruchin Kansal, Jeff Huth
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition. Codice articolo 30692321
Quantità: 10 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: New. pp. 228. Codice articolo 370857856
Quantità: 3 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New. Codice articolo 30692321-n
Quantità: 10 disponibili
Da: Revaluation Books, Exeter, Regno Unito
Hardcover. Condizione: Brand New. 189 pages. 9.50x6.50x0.75 inches. In Stock. Codice articolo __1138581046
Quantità: 1 disponibili
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Condizione: As New. Unread book in perfect condition. Codice articolo 30692321
Quantità: 10 disponibili
Da: Sigrun Wuertele buchgenie_de, Altenburg, Germania
Condizione: Sehr gut - gebraucht. Gebundene Ausgabe Sehr guter Zustand With a personal dedication from the author Ruchin Kansal Zustand: 2, Sehr gut - gebraucht, Gebundene Ausgabe Productivity Press , 2018 , Redefining Innovation: Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry. Dedication from the author Ruchin Kansal, Kansal, Ruchin Huth, Jeff, 1138581046, BU379579. Codice articolo BU379579
Quantità: 1 disponibili
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 228. Codice articolo 26376268895
Quantità: 3 disponibili
Da: GreatBookPricesUK, Woodford Green, Regno Unito
Condizione: New. Codice articolo 30692321-n
Quantità: 10 disponibili
Da: Biblios, Frankfurt am main, HESSE, Germania
Condizione: New. pp. 228. Codice articolo 18376268885
Quantità: 3 disponibili
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
Hardback. Condizione: New. New copy - Usually dispatched within 4 working days. Codice articolo B9781138581043
Quantità: 1 disponibili